Investigation announced for Investors in shares of Colony Capital, Inc. (NYSE: CLNY)
An investigation for investors in Colony Capital, Inc. (NYSE: CLNY) shares over potential securities laws violations.
Investors who purchased shares of Colony Capital, Inc. (NYSE: CLNY), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Colony Capital, Inc. (NYSE: CLNY) concerning whether a series of statements by Colony Capital, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Los Angeles, CA based Colony Capital, Inc. (NYSE: CLNY) is a leading global investment management firm with assets under management of $53 billion, which includes approximately $14 billion of assets under management from Digital Bridge, a leading global investment manager of digital infrastructure assets including cell towers, small cells, fiber and data centers. Colony Capital, Inc. reported that its annual Total Revenue declined from over $2.79 billion in 2017 to over $2.66 billion in 2018 and that its Net Loss increased from $197.89 million in 2017 to $519.6 million in 2018.
On November 8, 2019, Colony Capital, Inc announced its financial results for the third quarter of 2019. Among other results, the Company reported a GAAP net loss of $555 million, or $1.15 per share, which “notably included reductions of goodwill, real estate and provision for loan losses totaling $540.3 million . . . of which $387.0 million was attributable to the reduction of goodwill primarily as a result of the pending sale of the Company’s industrial investment management business and related real estate portfolio, and the decrease in management fees from Colony Credit Real Estate, Inc. resulting from impairments related to its portfolio bifurcation.”
Shares of Colony Capital, Inc. (NYSE: CLNY) declined from $6.14 per share in late September 2019 to as low as $4.78 per share on November 18, 2019.
Those who purchased shares of Colony Capital, Inc. (NYSE: CLNY) have certain options and should contact the Shareholders Foundation.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Colony Capital, Inc. (NYSE: CLNY) here
News-ID: 1877320 • Views: 325
More Releases from Shareholders Foundation
Lawsuit filed for Investors in shares of Green Dot Corporation (NYSE: GDOT)
An investor, who purchased shares of Green Dot Corporation (NYSE: GDOT), filed a lawsuit over alleged Securities Laws violations by Green Dot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Green Dot Corporation (NYSE: GDOT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 17, 2020. NYSE: GDOT investors should contact the Shareholders Foundation at email@example.com or
Investigation for Long-Term Investors in shares of Nektar Therapeutics (NASDAQ: …
An investigation was annpounced concerning potential breaches of fiduciary duties by certain directors and officers of Nektar Therapeutics. Investors who are current long term investors in Nektar Therapeutics (NASDAQ: NKTR) shares, have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: NKTR stocks follows a lawsuit filed against Nektar Therapeutics over
Deadline coming up on Jan. 20th in Lawsuit filed for Investors in shares of Cano …
A deadline is coming up on January 20, 2020 in the lawsuit filed for certain investors of Canopy Growth Corporation (NYSE: CGC) over alleged securities laws violations by Canopy Growth Corporation. Investors who purchased shares of Canopy Growth Corporation (NYSE: CGC) have certain options and there are strict and short deadlines running. Deadline: January 20, 2020. NYSE: CGC stockholders should contact the Shareholders Foundation at email@example.com or call +1(858) 779 -
Investigation for Investors in NYSE: LTHM shares announced over potential Securi …
Livent Corporation is under investigation concerning potential securities laws in connection with certain financial statements. Investors who purchased shares of Livent Corporation (NYSE: LTHM), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Livent Corporation (NYSE: LTHM) concerning whether a series of statements by Livent Corporation
More Releases for Colony
Develop business strategies Of Colony Counters Market
Colony counters estimate a liquid culture’s density of microorganisms. They specify the number of microbial colonies present on sample plates (agar plate, slide, mini gel, or Petri dish.) for maximized working efficiency in the lab. They accelerate medical and biology research procedures that demand the examination of microorganism growth rates in food, environmental, pharmaceutical, veterinary, and clinical laboratories. They are capable of judging the sample concentration, antibiotic testing, exact reagent,
Automatic Colony Counters Market Size, Share, Development by 2023
New report published by Global Info Research which offers insights on the global Automatic Colony Counters market. Automatic colony counting instrument is a high and new technology product developed for microbial colony analysis and micro particle size detection. Click to view the full report TOC, figure and tables： https://www.globalinforesearch.com/global-automatic-colony-counters-market_p87720.html Global Automatic Colony Counters Market: Forecast by Type / Application / Region This prosperity of the market
Bacterial Colony Counter Market Size 2018 BioLogics, WTW, Xylem, GeneScience
Global Bacterial Colony Counter market 2018 by ReportsQuest presents a professional and complete analysis of on the current Industry situation. The Global report includes Bacterial Colony Counter Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Bacterial Colony Counter market players and the future prospects from various angles in detail. Industry analysis is a
Global Automated Colony Counters Sales Market Report 2017
The Global Automated Colony Counters Sales Market Report 2017 is a professional and in-depth study on the current state of the Automated Colony Counters industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Automated Colony Counters market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing
Global Granulocyte-Colony Stimulating Factor Market Research Report 2017
Report Hive Market Research Released a New Research Report of 115 pages on Title " Global Granulocyte-Colony Stimulating Factor Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Granulocyte-province fortifying variable (G-CSF or GCSF), otherwise called state animating element 3 (CSF 3), is a glycoprotein that invigorates the bone marrow to create granulocytes and undifferentiated organisms and discharge them into the circulation system. In this report, the global Granulocyte-Colony Stimulating Factor
Europe Bacteria Colony Counter Market Report 2017
This report studies sales (consumption) of Bacteria Colony Counter in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering AID Boeckel Interscience Molecular Devices Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=825762&ptitle=Europe+Bacteria+Colony+Counter+Market+Report+2017&req=Sample S.M. Scientific Instruments Stuart Equipment Suntex Instruments Synbiosis UVP WTW Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate